InVita Healthcare Technologies Supports Blood Collectors During COVID-19 With Rapid Rollout of HemaControl Real-Time Inventory Management System

BALTIMORE, March 26, 2020 /PRNewswire/ — InVita Healthcare Technologies (formerly HemaTerra Technologies), a leading software provider for complex medical environments including blood and plasma collection, is offering its Rapid Rollout program to blood product collectors to assist in their time of need. Beginning immediately, InVita will implement its HemaControl product in 15 days or less for any blood product collector.  

HemaControl is the industry-leading hospital ordering and hospital demand planning system. It allows blood centers to predict future orders, integrate with donor recruitment and staffing activities, as well as allow hospitals to track critical blood orders through to the hospital blood bank. InVita is not charging for this Rapid Rollout program.

“We’re doing this because our blood center partners need help,” said Todd Collins, President and CEO of InVita Healthcare Technologies. “Collections are strained and the ability of blood centers to predict hospital demand is more important than ever. Having demand information integrated with your donor recruitment and collection staffing systems is vital to dealing with COVID-19. This isn’t about money. It’s about supporting our partners with tools that will help in weathering this storm.”

HemaControl empowers blood centers with the tools and visibility to fulfill hospital orders and predict future demand. It also integrates with recruitment, staffing, equipment maintenance and product QC. A typical implementation of HemaControl is 3-4 months. With blood center support, InVita will invest the resources to cut this implementation time by nearly 90%.

Blood centers can begin using the Rapid Rollout of HemaControl in up to 15 business days and at no cost for the duration of the pandemic and the rest of 2020. We want to help you get started today. Contact us

About InVita Healthcare Technologies | InVitaHealth.com
InVita Healthcare Technologies (formerly HemaTerra Technologies) provides healthcare technologies for complex medical environments. Its solutions optimize supply chain performance and visibility for blood, plasma, tissue, implants, and beyond. All for increased compliance, greater cost control, and improved patient safety. InVita Healthcare has offices in Baltimore, MD, Jacksonville, FL, Chicago and Lake Zurich, IL.

View original content to download multimedia:http://www.prnewswire.com/news-releases/invita-healthcare-technologies-supports-blood-collectors-during-covid-19-with-rapid-rollout-of-hemacontrol-real-time-inventory-management-system-301030382.html

SOURCE InVita Healthcare Technologies

Staff

Recent Posts

Optimind Pharma Closes First Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - July 8, 2024) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or…

10 mins ago

Element Science Receives Prestigious International Red Dot Design Award for Innovative Jewel® Patch Wearable Cardioverter Defibrillator

Novel technology recognized for its groundbreaking design and patient-centric innovationSAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative…

2 hours ago

StoryCorps Launches One Small Step America, a National Effort to Bridge Divides During a Contentious Election Year

One Small Step Pairs Strangers With Opposing Political Beliefs for One-on-One Conversations, Not to Debate…

5 hours ago

Navigate Announces Acquisition of Health Solutions, LLC

Positioning Navigate as a Leader in Comprehensive Wellbeing Solutions WEST DES MOINES, Iowa, July 8,…

5 hours ago

FDA Updates Guidance to Further Empower Companies to Address the Spread of Misinformation

SILVER SPRING, Md., July 8, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration…

5 hours ago

Goodix Launches Its Latest Automotive-Grade Bluetooth LE SoC and CGM Solutions at electronica China 2024

SHENZHEN, China, July 8, 2024 /PRNewswire/ -- Goodix Technology today unveiled its Continuous Glucose Monitoring…

5 hours ago